Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Point of Care Decision Support (POCDS) is a medical informatics company that develops clinical decision support (CDS) software to optimize the management of chronic conditions. Its primary offering, the ACG platform, provides evidence-based guidance for anticoagulation therapy, assisting healthcare providers in managing patients on warfarin and direct oral anticoagulants (DOACs). The software integrates directly into clinical workflows and electronic health records to improve safety, reduce adverse events, and ensure compliance with the latest medical guidelines. In 2021, the company was acquired by Abbott to bolster its point-of-care diagnostic and informatics capabilities. The platform is widely used to bridge the gap between diagnostic test results and therapeutic decisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Point of Care Decision Support.